Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AMN,Protein amnionless,11857,37,1.84 [1.08-3.13],0.0241447013858795
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,12048,37,1.66 [1.04-2.64],0.032309710941306
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,12146,37,1.68 [1.10-2.54],0.015255331776118
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ATP5F1D,"ATP synthase subunit delta, mitochondrial",10258,34,1.55 [1.15-2.09],0.0040924287288488
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",AZU1,Azurocidin,11719,37,1.35 [1.02-1.79],0.0345249259824324
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,11824,39,1.51 [1.03-2.19],0.0330247773577159
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BAP18,Chromatin complexes subunit BAP18,10586,35,1.47 [1.09-2.00],0.0121609763204594
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",10235,33,1.59 [1.06-2.41],0.0261361580770382
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BECN1,Beclin-1,10348,34,1.62 [1.01-2.61],0.0455901488329286
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BGLAP,Osteocalcin,10617,36,0.65 [0.47-0.89],0.0080610803951112
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BLMH,Bleomycin hydrolase,12247,40,2.30 [1.26-4.19],0.0064093077657129
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BRD3,Bromodomain-containing protein 3,10258,34,1.53 [1.02-2.29],0.0398727040882728
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",BTN2A1,Butyrophilin subfamily 2 member A1,12162,40,0.33 [0.11-0.99],0.0474003815659678
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C1GALT1C1,C1GALT1-specific chaperone 1,10258,34,2.26 [1.24-4.12],0.0076628101690157
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",C7orf50,Uncharacterized protein C7orf50,10586,35,2.89 [1.77-4.69],1.926091010244064e-05
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CAPN3,Calpain-3,10542,34,1.64 [1.01-2.69],0.0476414106486144
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CCAR2,Cell cycle and apoptosis regulator protein 2,10586,35,1.78 [1.41-2.25],1.4557770262269955e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD6,T-cell differentiation antigen CD6,12201,37,0.55 [0.32-0.96],0.0341574710737803
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD74,HLA class II histocompatibility antigen gamma chain,12201,37,0.36 [0.14-0.90],0.0283146769795662
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CD8A,T-cell surface glycoprotein CD8 alpha chain,12201,37,0.54 [0.30-0.98],0.0421096392333468
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEBPA,CCAAT/enhancer-binding protein alpha,10295,36,1.89 [1.31-2.72],0.0006197031767183
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEBPB,CCAAT/enhancer-binding protein beta,11861,38,1.75 [1.01-3.05],0.0474061930650652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CEP350,Centrosome-associated protein 350,10208,34,2.13 [1.31-3.46],0.0023003716385203
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR2,Complement factor H-related protein 2,10535,35,0.60 [0.38-0.95],0.0295044426170938
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CFHR4,Complement factor H-related protein 4,10604,35,0.54 [0.37-0.79],0.0015492071841769
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CGREF1,Cell growth regulator with EF hand domain protein 1,12108,41,0.41 [0.21-0.82],0.0111825773550046
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",12075,40,0.75 [0.57-0.99],0.0440517816073655
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CLNS1A,Methylosome subunit pICln,10316,33,2.36 [1.08-5.16],0.0314052878593681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTBS,Di-N-acetylchitobiase,10436,33,0.40 [0.18-0.89],0.0244158525076235
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CTRL,Chymotrypsin-like protease CTRL-1,10586,35,1.60 [1.00-2.57],0.0496883253585586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CWC15,Spliceosome-associated protein CWC15 homolog,10472,34,1.49 [1.04-2.13],0.0306554263510941
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CXCL14,C-X-C motif chemokine 14,11857,37,1.45 [1.11-1.90],0.006989544353074
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",10258,34,1.32 [1.03-1.70],0.0290385118508949
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DBH,Dopamine beta-hydroxylase,10576,33,0.76 [0.60-0.96],0.0238524496888584
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DDA1,DET1- and DDB1-associated protein 1,10258,34,1.61 [1.02-2.55],0.0414806372705867
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DOC2B,Double C2-like domain-containing protein beta,10316,33,2.44 [1.57-3.79],7.369523446878664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DPEP1,Dipeptidase 1,11999,39,1.94 [1.09-3.45],0.0242862951320642
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DSC2,Desmocollin-2,11992,37,0.30 [0.12-0.77],0.0128296256340806
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DXO,Decapping and exoribonuclease protein,10586,35,2.12 [1.16-3.90],0.0153168244099276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",DYNLT1,Dynein light chain Tctex-type 1,10316,33,1.59 [1.16-2.20],0.0041987193616345
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ECM1,Extracellular matrix protein 1,10327,34,0.43 [0.21-0.88],0.0197399496437732
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EDF1,Endothelial differentiation-related factor 1,10578,34,1.45 [1.06-2.00],0.0207006368395253
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ELOA,Elongin-A,12048,37,1.52 [1.10-2.10],0.0110026759430799
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ENTR1,Endosome-associated-trafficking regulator 1,10348,34,1.82 [1.16-2.85],0.0088225878267094
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EP300,Histone acetyltransferase p300,10295,36,1.88 [1.17-3.04],0.0096321875285787
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHA1,Ephrin type-A receptor 1,12151,40,0.40 [0.19-0.88],0.0218093897650663
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",EPHB6,Ephrin type-B receptor 6,11999,39,0.39 [0.15-0.96],0.0406593193826058
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ERI1,3'-5' exoribonuclease 1,10425,33,2.29 [1.32-3.98],0.0031325931660987
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FAM3C,Protein FAM3C,12085,41,0.38 [0.15-0.98],0.0451546760320128
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FCRL5,Fc receptor-like protein 5,12112,38,1.73 [1.10-2.72],0.0180110646833946
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FEN1,Flap endonuclease 1,11824,39,1.41 [1.10-1.82],0.0074809591191445
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FGF6,Fibroblast growth factor 6,10295,36,1.55 [1.01-2.38],0.0435862046838866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FMNL1,Formin-like protein 1,11815,37,1.40 [1.07-1.83],0.0130608092928346
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",FNDC1,Fibronectin type III domain-containing protein 1,10586,35,0.50 [0.25-0.99],0.0479312741601822
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GFAP,Glial fibrillary acidic protein,11801,38,0.48 [0.26-0.90],0.0218350205574726
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GIPR,Gastric inhibitory polypeptide receptor,10295,36,0.28 [0.11-0.67],0.0046086442868762
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLI2,Zinc finger protein GLI2,10295,36,2.10 [1.27-3.48],0.0040851391769657
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GLYR1,Putative oxidoreductase GLYR1,10542,34,1.49 [1.05-2.12],0.0244766201295857
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GNAS,Neuroendocrine secretory protein 55,10578,34,1.38 [1.03-1.85],0.0290083169613763
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GPKOW,G-patch domain and KOW motifs-containing protein,11815,37,1.98 [1.17-3.35],0.0112470422422276
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSAP,Gamma-secretase-activating protein,11824,39,1.36 [1.12-1.64],0.0020464629906352
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GSR,"Glutathione reductase, mitochondrial",10538,33,4.02 [1.05-15.35],0.0419310182917539
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",GZMH,Granzyme H,11861,38,1.42 [1.13-1.80],0.0031415960573512
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HDGFL2,Hepatoma-derived growth factor-related protein 2,10586,35,1.54 [1.01-2.35],0.0466839728513866
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,10578,34,1.89 [1.24-2.88],0.0028878303363006
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,10425,33,1.98 [1.07-3.66],0.0284314483073477
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,10258,34,1.70 [1.12-2.58],0.0121225418372905
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL10RB,Interleukin-10 receptor subunit beta,12162,40,0.28 [0.10-0.78],0.0148008452339652
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL13RA1,Interleukin-13 receptor subunit alpha-1,11970,38,0.17 [0.04-0.72],0.0161122564160922
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL2RG,Cytokine receptor common subunit gamma,10542,34,0.22 [0.07-0.74],0.0146518775530376
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IL5,Interleukin-5,11857,37,0.76 [0.60-0.98],0.0338726102822097
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",IMMT,MICOS complex subunit MIC60,10542,34,1.73 [1.06-2.82],0.0277156726477865
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ING1,Inhibitor of growth protein 1,11794,37,1.74 [1.21-2.51],0.0028803710004032
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",10578,34,1.83 [1.24-2.71],0.0024237235338259
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KCTD5,BTB/POZ domain-containing protein KCTD5,10389,35,1.81 [1.10-3.00],0.0202211154022509
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,10208,34,0.34 [0.15-0.80],0.0127817093961606
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",KLK1,Kallikrein-1,11988,39,1.23 [1.01-1.51],0.0438193883686743
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LAMTOR5,Ragulator complex protein LAMTOR5,10542,34,1.88 [1.22-2.89],0.004004115617372
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LPCAT2,Lysophosphatidylcholine acyltransferase 2,12048,37,1.70 [1.24-2.31],0.0008616453779628
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LY96,Lymphocyte antigen 96,12020,39,2.26 [1.19-4.27],0.0122365545190672
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",LYAR,Cell growth-regulating nucleolar protein,11824,39,1.62 [1.27-2.06],0.0001078593120439
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAG,Myelin-associated glycoprotein,10316,33,1.91 [1.05-3.46],0.033670277438975
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MAPK13,Mitogen-activated protein kinase 13,10208,34,1.64 [1.04-2.59],0.0323375397943623
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MDM1,Nuclear protein MDM1,10316,33,3.06 [1.29-7.25],0.010962479235486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MFAP3,Microfibril-associated glycoprotein 3,11861,38,1.59 [1.07-2.36],0.0213225523177593
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MKI67,Proliferation marker protein Ki-67,10295,36,2.03 [1.39-2.98],0.0002766909658908
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MNAT1,CDK-activating kinase assembly factor MAT1,10425,33,1.93 [1.22-3.04],0.005044212633681
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MNDA,Myeloid cell nuclear differentiation antigen,12087,41,1.29 [1.05-1.58],0.0159215475759486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MORC3,MORC family CW-type zinc finger protein 3,10586,35,2.41 [1.35-4.31],0.0029754560485437
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",10316,33,1.71 [1.12-2.59],0.0122142486400498
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NADK,NAD kinase,12108,41,1.50 [1.06-2.11],0.0207046841548499
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NBN,Nibrin,11857,37,1.42 [1.02-1.98],0.037063352729254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",11824,39,0.52 [0.32-0.85],0.008329848113026
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NECTIN2,Nectin-2,12085,41,0.32 [0.12-0.89],0.0280620106219649
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NLGN1,Neuroligin-1,10316,33,1.43 [1.06-1.94],0.0193099289400617
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,12020,39,1.34 [1.02-1.75],0.0364401392018742
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOP56,Nucleolar protein 56,10258,34,0.67 [0.61-0.74],2.5070145189813315e-16
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",NOTCH2,Neurogenic locus notch homolog protein 2,10617,36,4.75 [1.24-18.23],0.0230240582526197
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PADI2,Protein-arginine deiminase type-2,11857,37,1.53 [1.15-2.05],0.0035200491247513
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PARP1,Poly [ADP-ribose] polymerase 1,12076,37,1.43 [1.07-1.93],0.0173243773088586
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PDCD1,Programmed cell death protein 1,12176,37,0.45 [0.21-0.93],0.0321776058610973
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PECR,Peroxisomal trans-2-enoyl-CoA reductase,10348,34,2.90 [1.86-4.53],2.6907677881814846e-06
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PNLIP,Pancreatic triacylglycerol lipase,10602,33,1.69 [1.03-2.78],0.0386627762380482
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",12048,37,1.88 [1.15-3.05],0.0113693616241923
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PREB,Prolactin regulatory element-binding protein,11857,37,0.21 [0.07-0.64],0.0063922695053744
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRG3,Proteoglycan 3,10617,36,0.55 [0.31-0.97],0.0386440877517692
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",PRR5,Proline-rich protein 5,10295,36,1.82 [1.23-2.70],0.002948502306254
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RAB44,Ras-related protein Rab-44,10542,34,1.52 [1.01-2.30],0.0444571571893718
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RFC4,Replication factor C subunit 4,10542,34,3.95 [1.45-10.80],0.0073813489426048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF168,E3 ubiquitin-protein ligase RNF168,10295,36,1.72 [1.06-2.79],0.0281595504187322
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RNF4,E3 ubiquitin-protein ligase RNF4,10425,33,0.40 [0.19-0.86],0.0186286301155611
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",RPL14,60S ribosomal protein L14,10348,34,1.98 [1.17-3.35],0.0107461710271029
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SAFB2,Scaffold attachment factor B2,10578,34,2.48 [1.41-4.38],0.0016840443656915
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELE,E-selectin,12247,40,0.57 [0.34-0.98],0.0403606441214563
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SELL,L-selectin,10623,35,0.25 [0.08-0.83],0.0237202118783463
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SERPINB8,Serpin B8,12217,37,1.41 [1.01-1.97],0.0453717439907545
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SFTPD,Pulmonary surfactant-associated protein D,12108,41,0.62 [0.40-0.94],0.0246787813037683
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SHH,Sonic hedgehog protein,10295,36,0.43 [0.19-0.98],0.0457094558209396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIGLEC6,Sialic acid-binding Ig-like lectin 6,12195,37,0.36 [0.16-0.82],0.0148362923853165
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SIT1,Signaling threshold-regulating transmembrane adapter 1,11857,37,0.55 [0.32-0.95],0.03170430283669
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SLC39A5,Zinc transporter ZIP5,12076,37,0.51 [0.29-0.90],0.0188577803603017
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SMNDC1,Survival of motor neuron-related-splicing factor 30,10538,34,1.47 [1.06-2.05],0.0209663633716953
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNRPB2,U2 small nuclear ribonucleoprotein B'',10586,35,1.70 [1.26-2.29],0.0004931603530174
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNU13,NHP2-like protein 1,10258,34,1.54 [1.14-2.09],0.0048036584688218
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SNX5,Sorting nexin-5,10348,34,2.29 [1.01-5.18],0.0470358962451874
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPAG1,Sperm-associated antigen 1,10578,34,1.67 [1.18-2.35],0.0036214068528048
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPRR3,Small proline-rich protein 3,10586,35,1.51 [1.00-2.27],0.0493496605789105
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SPTLC1,Serine palmitoyltransferase 1,10586,35,1.87 [1.17-2.98],0.0084057150445027
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SRP14,Signal recognition particle 14 kDa protein,12048,37,1.60 [1.07-2.39],0.0220291369024601
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",10295,36,1.63 [1.10-2.42],0.0158292791621438
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",STAB2,Stabilin-2,10617,36,0.38 [0.17-0.86],0.0205533066514971
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",SUGP1,SURP and G-patch domain-containing protein 1,10538,34,2.01 [1.08-3.74],0.0276649098312079
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TAP1,Antigen peptide transporter 1,10425,33,1.45 [1.04-2.03],0.0274977559257073
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TCOF1,Treacle protein,10600,35,2.21 [1.26-3.86],0.0053638336036102
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TFF3,Trefoil factor 3,12099,39,0.36 [0.14-0.92],0.0334340585982619
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TGM2,Protein-glutamine gamma-glutamyltransferase 2,12092,41,1.46 [1.03-2.08],0.0335981515006089
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THOP1,Thimet oligopeptidase,12035,41,2.27 [1.06-4.85],0.0343758031473396
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",THRAP3,Thyroid hormone receptor-associated protein 3,10258,34,0.48 [0.43-0.53],5.497579680935366e-44
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TIMP2,Metalloproteinase inhibitor 2,10600,35,0.14 [0.03-0.65],0.0121466213987356
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,10538,34,1.77 [1.09-2.89],0.0214561012978238
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,12138,40,0.45 [0.30-0.68],0.000136227143608
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,12020,39,0.54 [0.30-0.95],0.0315705213114486
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,12231,40,0.31 [0.11-0.91],0.0331935106979228
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TOR1AIP1,Torsin-1A-interacting protein 1,10348,34,1.55 [1.01-2.37],0.0434144494536489
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TPM3,Tropomyosin alpha-3 chain,10258,34,1.76 [1.00-3.09],0.0492744912882836
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",TREML2,Trem-like transcript 2 protein,12112,38,0.38 [0.16-0.92],0.0320657174729964
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",UPK3BL1,Uroplakin-3b-like protein 1,10402,33,1.47 [1.09-1.98],0.0107503712572633
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",VIPR1,Vasoactive intestinal polypeptide receptor 1,10348,34,3.67 [1.72-7.81],0.000742273338609
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",WAS,Wiskott-Aldrich syndrome protein,11857,37,0.62 [0.40-0.97],0.0376527746781388
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",YY1,Transcriptional repressor protein YY1,10295,36,2.53 [1.22-5.24],0.0122086330906955
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBP1,Z-DNA-binding protein 1,10295,36,1.80 [1.15-2.81],0.010130788863374
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZBTB17,Zinc finger and BTB domain-containing protein 17,11861,38,1.64 [1.04-2.57],0.0330586944845995
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZCCHC8,Zinc finger CCHC domain-containing protein 8,10258,34,1.46 [1.05-2.04],0.0260199889972012
"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",ZHX2,Zinc fingers and homeoboxes protein 2,10586,35,1.96 [1.27-3.04],0.0023662351281506
